Myricetin: A dietary molecule with diverse biological activities

Nutrients

Volumn 8, Issue 2, 2016, Pages

  Semwal, Deepak Kumar ^a   Semwal, Ruchi Badoni ^a   Combrinck, Sandra ^a   Viljoen, Alvaro ^a  

^a TSHWANE UNIVERSITY OF TECHNOLOGY   (South Africa)

Author keywords

Anti alzheimer activity; Anti HIV activity; Anti oxidant activity; Cytotoxicity; Myricetin; Polyphenol

Indexed keywords

5,7 DIHYDROXY 3,3',4',5' TETRAMETHOXYFLAVONE; CYCLIN DEPENDENT KINASE 7; CYCLOOXYGENASE 2; CYTOCHROME P450 1A1; DNA TOPOISOMERASE; FISETIN; FLAVONOID; GELATINASE B; INTERLEUKIN 1BETA; JANUS KINASE 1; KAEMPFEROL; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; METHOXYPHLOROACETOPHENONE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MORIN; MYRICETIN; MYRICITRIN; NITRIC OXIDE; PROSTACYCLIN; PROTEIN C FOS; PROTEIN C JUN; PROTEIN KINASE FYN; PROTEIN P53; QUERCETIN; REACTIVE OXYGEN METABOLITE; SODIUM TRIMETHYLGALLATE; STAT3 PROTEIN; SUPEROXIDE DISMUTASE; TRIMETHYLGALLIC ANHYDRIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; ANTIOXIDANT; NEUROPROTECTIVE AGENT; PLANT EXTRACT;

ALZHEIMER DISEASE; ANALGESIC ACTIVITY; ANTI ALLERGIC ACTIVITY; ANTI PLATELET AGGREGATION ACTIVITY; ANTIDIABETIC ACTIVITY; ANTIHYPERTENSIVE ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; BONE DISEASE; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CHEMICAL REACTION; CHEMICAL STRUCTURE; DNA REPAIR; DRUG ACTIVITY; DRUG MECHANISM; DRUG SYNTHESIS; EYE DISEASE; HUMAN; HYPOURICEMIA; IC50; IMMUNOMODULATION; LIPID OXIDATION; LIPID PEROXIDATION; LIVER PROTECTION; NONHUMAN; NUTRITIONAL VALUE; PARKINSON DISEASE; REVIEW; STRUCTURE ACTIVITY RELATION; TOXICITY TESTING; ANIMAL; CHEMISTRY; DIET; EDIBLE PLANT; NERVOUS SYSTEM DISEASES; PHYTOTHERAPY;

ANIMALS; ANTI-INFECTIVE AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTIOXIDANTS; DIET; FLAVONOIDS; HUMANS; NERVOUS SYSTEM DISEASES; NEUROPROTECTIVE AGENTS; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, EDIBLE;

EID: 84958526856     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu8020090     Document Type: Review

References (220)

1. Lau-Cam, C.A.; Chan, H.H. Flavonoids from Comptonia peregrine. Phytochemistry 1973, 12, 1829. [CrossRef].
2. Jones, J.R.; Lebar, M.D.; Jinwal, U.K.; Abisambra, J.F.; Koren, J.; Blair, L.; O'Leary, J.C.; Davey, Z.; Trotter, J.; Johnson, A.G.; et al. The diarylheptanoid (+)-aR,11S-myricanol and two flavones from bayberry (Myrica cerifera) destabilize the microtubule-associated protein tau. J. Nat. Prod. 2011, 74, 38-44. [CrossRef] [PubMed].
3. Umadevi, I.; Daniel, M.; Sabnis, S.D. Chemotaxonomic studies on some members of Anacardiaceae. Proc. Plant Sci. 1988, 98, 205-208.
4. El-Kader, A.M.A.; El-Readi, M.Z.; Ahmed, A.S.; Nafady, A.M.;Wink, M.; Ibraheim, Z.Z. Polyphenols from aerial parts of Polygonum bellardii and their biological activities. Pharm. Biol. 2013, 51, 1026-1034. [CrossRef] [PubMed].
5. Hergert, H.L. The flavonoids of lodgepole pine bark. J. Org. Chem. 1956, 21, 534-537. [CrossRef].
6. Chua, L.S.; Latiff, N.A.; Lee, S.Y.; Lee, C.T.; Sarmidi, M.R.; Aziz, R.A. Flavonoids and phenolic acids from Labisia pumila (Kacip Fatimah). Food Chem. 2011, 127, 1186-1192. [CrossRef] [PubMed].
7. De Leo, M.; Braca, A.; Sanogo, R.; Cardile, V.; deTommasi, N.; Russo, A. Antiproliferative activity of Pteleopsis suberosa leaf extract and its flavonoid components in human prostate carcinoma cells. Planta Med. 2006, 72, 604-610. [CrossRef] [PubMed].
8. Kong, N.N.; Fang, S.T.; Wang, J.H.; Wang, Z.H.; Xia, C.H. Two new flavonoid glycosides from the halophyte Limonium franchetii. J. Asian Nat. Prod. Res. 2014, 16, 370-375. [CrossRef] [PubMed].
9. Yao, Y.; Lin, G.; Xie, Y.; Ma, P.; Li, G.; Meng, Q.; Wu, T. Preformulation studies of myricetin: A natural antioxidant flavonoid. Pharmazie 2014, 69, 19-26. [PubMed].
10. Perkin, A.G.; Hummel, J.J. LXXVI-The colouring principle contained in the bark of Myrica nagi Part I. J. Chem. Soc. Trans. 1896, 69, 1287-1294. [CrossRef].
11. Perkin, A.G. XXI.-Myricetin. Part II. J. Chem. Soc. Trans. 1902, 81, 203-210. [CrossRef].
12. Perkin, A.G. CXCIII. Myricetin. Part III. J. Chem. Soc. Trans. 1911, 99, 1721-1725. [CrossRef].
13. Lin, G.B.; Xie, Y.; Li, G.W. Research advances of myricetin. J. Int. Pharm. Res. 2012, 39, 483-487.
14. Rao, K.V.; Seshadri, T.R. Nuclear oxidation in the flavone series-Part IV. New synthesis of herbacetin and hibiscetin. Proc. Indian Acad. Sci. A 1948, 25, 444-448.
15. Tranchimand, S.; Tron, T.; Gaudin, C.; Iacazio, G. First chemical synthesis of three natural depsides involved in flavonol catabolism and related to quercetinase catalysis. Synth. Commun. 2006, 36, 587-597. [CrossRef].
16. Dean, H.F.; Nierenstein, M. Attempts to synthesize myricetin. J. Am. Chem. Soc. 1925, 47, 1676-1684. [CrossRef].
17. Kalff, J.; Robinson, R. XXVIII.-A synthesis of myricetin and of a galangin monomethyl ether occurring in galanga root. J. Chem. Soc. Trans. 1925, 127, 181-184. [CrossRef].
18. Rao, K.V.; Seshadri, T.R. Nuclear oxidation in flavones and related compounds-Part XVI. A new synthesis of myricetin. Proc. Indian Acad. Sci. A 1948, 28, 210-215.
19. Ong, K.C.; Khoo, H.E. Biological effects of myricetin. Gen. Pharmacol. 1997, 29, 121-126. [CrossRef].
20. Qu, G.Z.; Si, C.L.; Wang, M.H. Antioxidant constituents from Leonurus japonicas. Nat. Prod. Sci. 2006, 12, 197-200.
21. Sim, G.S.; Lee, B.C.; Ho, S.C.; Jae, W.L.; Kim, J.H.; Lee, D.H.; Kim, J.H.; Pyo, H.B.; Dong, C.M.; Oh, K.W.; et al. Structure activity relationship of antioxidative property of flavonoids and inhibitory effect on matrix metalloproteinase activity in UVA-irradiated human dermal fibroblast. Arch. Pharm. Res. 2007, 30, 290-298. [CrossRef] [PubMed].
22. Gendaram, O.; Choi, Y.H.; Kim, Y.S.; Ryu, S.Y. Anti-oxidative and antibacterial constituents from Sedum hybridum. Nat. Prod. Sci. 2011, 17, 279-284.
23. Chaabi, M.; Beghidja, N.; Benayache, S.; Lobstein, A. Activity-guided isolation of antioxidant principles from Limoniastrum feei (Girard) Batt. Z. Naturforsch. C 2008, 63, 801-807. [CrossRef] [PubMed].
24. Mahjoub, M.A.; Ammar, S.; Edziri, H.; Mighri, N.; Bouraoui, A.; Mighri, Z. Anti-inflammatory and antioxidant activities of some extracts and pure natural products isolated from Rhus tripartitum (Ucria). Med. Chem. Res. 2010, 19, 271-282. [CrossRef].
25. Yoshimura, M.; Yamakami, S.; Amakura, Y.; Yoshida, T. Diarylheptanoid sulfates and related compounds from Myrica rubra bark. J. Nat. Prod. 2012, 75, 1798-1802. [CrossRef] [PubMed].
26. Pandey, K.B.; Rizvi, S.I. Ferric reducing and radical scavenging activities of selected important polyphenols present in foods. Int. J. Food Prop. 2012, 15, 702-708. [CrossRef].
27. Ratty, A.K.; Das, N.P. Effects of flavonoids on nonenzymatic lipid peroxidation: Structure-activity relationship. Biochem. Med. Metab. Biol. 1988, 39, 69-79. [CrossRef].
28. Zhang, D.; Xie, L.; Jia, G.; Cai, S.; Ji, B.; Liu, Y.; Wu, W.; Zhou, F.; Wang, A.; Chu, L.; et al. Comparative study on antioxidant capacity of flavonoids and their inhibitory effects on oleic acid-induced hepatic steatosis in vitro. Eur. J. Med. Chem. 2011, 46, 4548-4558. [CrossRef] [PubMed].
29. Rostoka, E.; Baumane, L.; Isajevs, S.; Line, A.; Dzintare, M.; Svirina, D.; Sharipova, J.; Silina, K.; Kalvinsh, I.; Sjakste, N. Effects of kaempferol and myricetin on inducible nitric oxide synthase expression and nitric oxide production in rats. Basic Clin. Pharmacol. Toxicol. 2010, 106, 461-466. [CrossRef] [PubMed].
30. Sueishi, Y.; Hori, M. Nitric oxide scavenging rates of solubilized resveratrol and flavonoids. Nitric Oxide 2013, 29, 25-29. [CrossRef] [PubMed].
31. Valdez, L.B.; Álvarez, S.; Zaobornyj, T.; Boveris, A. Polyphenols and red wine as antioxidants against peroxynitrite and other oxidants. Biol. Res. 2004, 37, 279-286. [CrossRef] [PubMed].
32. Jimenez, M.; Garcia-Carmona, F. Myricetin, an antioxidant flavonol, is a substrate of polyphenol oxidase. J. Sci. Food Agric. 1999, 79, 1993-2000. [CrossRef].
33. Rusak, G.; Gutzeit, H.O.; Müller, J.L. Structurally related flavonoids with antioxidative properties differentially affect cell cycle progression and apoptosis of human acute leukemia cells. Nutr. Res. 2005, 25, 143-155. [CrossRef].
34. Husain, S.R.; Cillard, J.; Cillard, P. Hydroxyl radical scavenging activity of flavonoids. Phytochemistry 1987, 26, 2489-2491. [CrossRef].
35. Soucek, P.; Kondrová, E.; Hěrmánek, J.; Stopka, P.; Boumendjel, A.; Ueng, Y.F.; Gut, I. New model system for testing effects of flavonoids on doxorubicin-related formation of hydroxyl radicals. Anticancer Drugs 2011, 22, 176-184. [CrossRef] [PubMed].
36. Cao, G.; Sofie, E.; Prior, R.L. Peroxyl radical absorbing antioxidant activities of flavonoids. FASEB J. 1996, 10, A821.
37. Ah Kang, K.; Wang, Z.H.; Zhang, R.; Piao, M.J.; Kim, K.C.; Kang, S.S.; Kim, Y.W.; Lee, J.; Park, D.; Hyun, J.W. Myricetin protects cells against oxidative stress-induced apoptosis via regulation of PI3K/Akt and MAPK signaling pathways. Int. J. Mol. Sci. 2010, 11, 4348-4360. [CrossRef] [PubMed].
38. Wang, Z.H.; Ah Kang, K.; Zhang, R.; Piao, M.J.; Jo, S.H.; Kim, J.S.; Kang, S.S.; Lee, J.S.; Park, D.H.; Hyun, J.W. Myricetin suppresses oxidative stress-induced cell damage via both direct and indirect antioxidant action. Environ. Toxicol. Pharmacol. 2010, 29, 12-18. [CrossRef] [PubMed].
39. Duthie, S.J.; Collins, A.R.; Duthie, G.G.; Dobson, V.L. Quercetin and myricetin protect against hydrogen peroxide-induced DNA damage (strand breaks and oxidised pyrimidines) in human lymphocytes. Mutat. Res. 1997, 393, 223-231. [CrossRef].
40. Duthie, S.J.; Dobson, V.L. Dietary flavonoids protect human colonocyte DNA from oxidative attack in vitro. Eur. J. Nutr. 1999, 38, 28-34. [CrossRef] [PubMed].
41. Miyajima, Y.; Kikuzaki, H.; Hisamoto, M.; Nakatani, N. Antioxidative polyphenols from berries of Pimenta dioica. Biofactors 2004, 22, 301-303. [CrossRef].
42. Sahu, S.C.; Gray, G.C. Interactions of flavonoids, trace metals, and oxygen: Nuclear DNA damage and lipid peroxidation induced by myricetin. Cancer Lett. 1993, 70, 73-79. [CrossRef].
43. Abalea, V.; Cillard, J.; Dubos, M.P.; Sergent, O.; Cillard, P.; Morel, I. Repair of iron-induced DNA oxidation by the flavonoid myricetin in primary rat hepatocyte cultures. Free Radic. Biol. Med. 1999, 26, 1457-1466. [CrossRef].
44. Morel, I.; Abaléa, V.; Sergent, O.; Cillard, P.; Cillard, J. Involvement of phenoxyl radical intermediates in lipid antioxidant action of myricetin in iron-treated rat hepatocyte culture. Biochem. Pharmacol. 1998, 55, 1399-1404. [CrossRef].
45. Bennett, C.J.; Caldwell, S.T.; McPhail, D.B.; Morrice, P.C.; Duthie, G.G.; Hartley, R.C. Potential therapeutic antioxidants that combine the radical scavenging ability of myricetin and the lipophilic chain of vitamin E to effectively inhibit microsomal lipid peroxidation. Bioorg. Med. Chem. 2004, 12, 2079-2098. [CrossRef] [PubMed].
46. Chen, W.; Li, Y.; Li, J.; Han, Q.; Ye, L.; Li, A. Myricetin affords protection against peroxynitrite-mediated DNA damage and hydroxyl radical formation. Food Chem. Toxicol. 2011, 49, 2439-2444. [CrossRef] [PubMed].
47. Yu, J.S.; Kim, A.K. Effect of myricetin combined with vitamin C or vitamin E on antioxidant enzyme system in murine melanoma cells. Korean J. Pharmacogn. 2004, 35, 357-363.
48. Do Nascimento, A.J.; Henneberg, R.; Otuki, M.F.; Furman, A.E.F.; Hermann, P.; Leonart, M.S.S. Protective effect of favonoids against reactive oxygen species production in sickle cell anemia patients treated with hydroxyurea. Rev. Bras. Hematol. Hemoter. 2013, 35, 52-55.
49. Robak, J.; Gryglewski, R.J. Flavonoids are scavengers of superoxide anions. Biochem. Pharmacol. 1988, 37, 837-841. [CrossRef].
50. Costantino, L.; Rastelli, G.; Albasini, A. Inhibitory activity of flavonols towards the xanthine oxidase enzyme. Int. J. Pharm. 1992, 86, 17-23. [CrossRef].
51. Qin, S.; Chen, J.; Tanigawa, S.; Hou, D.X. Microarray and pathway analysis highlight Nrf2/ARE-mediated expression profiling by polyphenolic myricetin. Mol. Nutr. Food Res. 2013, 57, 435-446. [CrossRef] [PubMed].
52. Zhao, X.; Zhang, X. Comparisons of cytoprotective effects of three flavonoids against human hepatocytes oxidative injury induced by hydrogen peroxide or carbon tetrachloride in vitro. J. Med. Plants Res. 2009, 3, 776-784.
53. Laughton, M.J.; Halliwell, B.; Evans, P.J.; Hoult, J.R.S. Antioxidant and pro-oxidant actions of the plant phenolics quercetin, gossypol and myricetin. Effects on lipid peroxidation, hydroxyl radical generation and bleomycin-dependent damage to DNA. Biochem. Pharmacol. 1989, 38, 2859-2865. [CrossRef].
54. Chobot, V.; Hadacek, F. Exploration of pro-oxidant and antioxidant activities of the flavonoid myricetin. Redox Rep. 2011, 16, 242-247. [CrossRef] [PubMed].
55. Duthie, G.; Morrice, P. Antioxidant capacity of flavonoids in hepatic microsomes is not reflected by antioxidant effects in vivo. Oxid. Med. Cell. Longev. 2012, 2012, 165127. [CrossRef] [PubMed].
56. Fraga, C.G.; Martino, V.S.; Ferraro, G.E.; Coussio, J.D.; Boveris, A. Flavonoids as antioxidants evaluated by in vitro and in situ liver chemiluminescence. Biochem. Pharmacol. 1987, 36, 717-720. [CrossRef].
57. Pandey, K.B.; Mishra, N.; Rizvi, S.I. Myricetin may provide protection against oxidative stress in type 2 diabetic erythrocytes. Z. Naturforsch. C 2009, 64, 626-630. [CrossRef] [PubMed].
58. 2+-loaded brain neurons. Brain Res. 1994, 635, 125-129. [CrossRef].
59. Teissedre, P.L.; Frankel, E.N.; Waterhouse, A.L.; Peleg, H.; German, J.B. Inhibition of in vitro human LDL oxidation by phenolic antioxidants from grapes and wines. J. Sci. Food Agric. 1996, 70, 55-61. [CrossRef].
60. Sadasivam, K.; Kumaresan, R. Antioxidant behavior of mearnsetin and myricetin flavonoid compounds-A DFT study. Spectrochim. Acta A 2011, 79, 282-293. [CrossRef] [PubMed].
61. Xie, H.J.; Mou, W.S.; Lin, F.R.; Xu, J.H.; Lei, Q.F.; Fang, W.J. Radical scavenging activity of myricetin. Acta PhysicoChim. Sin. 2013, 29, 1421-1432.
62. Wang, L.; Tu, Y.C.; Lian, T.W.; Hung, J.T.; Yen, J.H.;Wu, M.J. Distinctive antioxidant and antiinflammatory effects of flavonols. J. Agric. Food Chem. 2006, 54, 9798-9804. [CrossRef] [PubMed].
63. Mira, L.; Fernandez, M.T.; Santos, M.; Rocha, R.; Florêncio, M.H.; Jennings, K.R. Interactions of flavonoids with iron and copper ions: A mechanism for their antioxidant activity. Free Radic. Res. 2002, 36, 1199-1208. [CrossRef] [PubMed].
64. Justino, G.C.; Vieira, A.J.S.C. Antioxidant mechanisms of quercetin and myricetin in the gas phase and in solution- A comparison and validation of semi-empirical methods. J. Mol. Model. 2010, 16, 863-876. [CrossRef] [PubMed].
65. Jung, S.K.; Lee, K.W.; Kim, H.Y.; Oh, M.H.; Byun, S.; Lim, S.H.; Heo, Y.S.; Kang, N.J.; Bode, A.M.; Dong, Z.; et al. Myricetin suppresses UVB-induced wrinkle formation and MMP-9 expression by inhibiting Raf. Biochem. Pharmacol. 2010, 79, 1455-1461. [CrossRef] [PubMed].
66. Huang, J.H.; Huang, C.C.; Fang, J.Y.; Yang, C.; Chan, C.M.;Wu, N.L.; Kang, S.W.; Hung, C.F. Protective effects of myricetin against ultraviolet-B-induced damage in human keratinocytes. Toxicol. Vitro 2010, 24, 21-28. [CrossRef] [PubMed].
67. Sung, K.J.; Ki, W.L.; Byun, S.; Nam, J.K.; Sung, H.L.; Heo, Y.S.; Bode, A.M.; Bowden, G.T.; Hyong, J.L.; Dong, Z. Myricetin suppresses UVB-induced skin cancer by targeting Fyn. Cancer Res. 2008, 68, 6021-6029.
68. Kim, W.; Yang, J.H.; Youn, H.; Yun, Y.J.; Seong, K.M.; Youn, B. Myricetin inhibits Akt survival signaling and induces bad-mediated apoptosis in a low dose ultraviolet (UV)-B-irradiated hacat human immortalized keratinocytes. J. Radiat. Res. 2010, 51, 285-296. [CrossRef] [PubMed].
69. Kumamoto, T.; Fujii, M.; Hou, D.X. Akt is a direct target for myricetin to inhibit cell transformation. Mol. Cell. Biochem. 2009, 332, 33-41. [CrossRef] [PubMed].
70. Chang, H.; Mi, M.T.; Gu, Y.Y.; Yuan, J.L.; Ling, W.H.; Lin, H. Effects of flavonoids with different structures on proliferation of leukemia cell line HL-60. Chin. J. Cancer 2007, 26, 1309-1314.
71. Romanouskaya, T.V.; Grinev, V.V. Cytotoxic effect of flavonoids on leukemia cells and normal cells of human blood. Bull. Exp. Biol. Med. 2009, 148, 57-59. [CrossRef] [PubMed].
72. Lazaro, M.L.; Willmore, E.; Austin, C.A. The dietary flavonoids myricetin and fisetin act as dual inhibitors of DNA topoisomerases I and II in cells. Mutat. Res. 2010, 696, 41-47. [CrossRef] [PubMed].
73. Constantinou, A.; Mehta, R.; Runyan, C.; Rao, K.; Vaughan, A.; Moon, R. Flavonoids as DNA topoisomerase antagonists and poisons: Structure-activity relationships. J. Nat. Prod. 1995, 58, 217-225. [CrossRef] [PubMed].
74. Kang, N.J.; Jung, S.K.; Lee, K.W.; Lee, H.J. Myricetin is a potent chemopreventive phytochemical in skin carcinogenesis. Ann. N. Y. Acad. Sci. 2011, 1229, 124-132. [CrossRef] [PubMed].
75. Lee, K.W.; Kang, N.J.; Rogozin, E.A.; Kim, H.-G.; Cho, Y.Y.; Bode, A.M.; Lee, H.J.; Surh, Y.J.; Bowden, G.T.; Dong, Z. Myricetin is a novel natural inhibitor of neoplastic cell transformation and MEK1. Carcinogenesis 2007, 28, 1918-1927. [CrossRef] [PubMed].
76. Kumamoto, T.; Fujii, M.; Hou, D.X. Myricetin directly targets JAK1 to inhibit cell transformation. Cancer Lett. 2009, 275, 17-26. [CrossRef] [PubMed].
77. Ichimatsu, D.; Nomura, M.; Nakamura, S.; Moritani, S.; Yokogawa, K.; Kobayashi, S.; Nishioka, T.; Miyamoto, K.I. Structure-activity relationship of flavonoids for inhibition of epidermal growth factor-induced transformation of JB6 CI 41 cells. Mol. Carcinog. 2007, 46, 436-445. [CrossRef] [PubMed].
78. Siegelin, M.D.; Gaiser, T.; Habel, A.; Siegelin, Y. Myricetin sensitizes malignant glioma cells to TRAIL-mediated apoptosis by down-regulation of the short isoform of FLIP and bcl-2. Cancer Lett. 2009, 283, 230-238. [CrossRef] [PubMed].
79. Loizzo, M.R.; Said, A.; Tundis, R.; Hawas, U.W.; Rashed, K.; Menichini, F.; Frega, N.G.; Menichini, F. Antioxidant and antiproliferative activity of Diospyros lotus L. extract and isolated compounds. Plant Foods Hum. Nutr. 2009, 64, 264-270. [CrossRef] [PubMed].
80. Rodgers, E.H.; Grant, M.H. The effect of the flavonoids, quercetin, myricetin and epicatechin on the growth and enzyme activities of MCF7 human breast cancer cells. Chem. Biol. Interact. 1998, 116, 213-228. [CrossRef].
81. Mori, A.; Nishino, C.; Enoki, N.; Tawata, S. Cytotoxicity of plant flavanoids against HeLa cells. Phytochemistry 1988, 27, 1017-1020. [CrossRef].
82. Alonso, S.G.; Collins, V.J.; Vauzour, D.; Mateos, A.R.; Corona, G.; Spencer, J.P.E. Inhibition of colon adenocarcinoma cell proliferation by flavonols is linked to a G2/M cell cycle block and reduction in cyclin D1 expression. Food Chem. 2012, 130, 493-500. [CrossRef].
83. Shiomi, K.; Kuriyama, I.; Yoshida, H.; Mizushina, Y. Inhibitory effects of myricetin on mammalian DNA polymerase, topoisomerase and human cancer cell proliferation. Food Chem. 2013, 139, 910-918. [CrossRef] [PubMed].
84. Ko, C.H.; Shen, S.C.; Lee, T.J.F.; Chen, Y.C. Myricetin inhibits matrix metalloproteinase 2 protein expression and enzyme activity in colorectal carcinoma cells. Mol. Cancer Ther. 2005, 4, 281-290. [PubMed].
85. Morales, P.; Haza, A.I. Selective apoptotic effects of piceatannol and myricetin in human cancer cells. J. Appl. Toxicol. 2012, 32, 986-993. [CrossRef] [PubMed].
86. Chaudhary, A.;Willett, K.L. Inhibition of human cytochrome CYP1 enzymes by flavonoids of St. John's wort. Toxicology 2006, 217, 194-205. [CrossRef] [PubMed].
87. Master, Z.; Chaudhary, A.; Sutter, T.R.; Willett, K.L. Effects of flavonoids on CYP1 expression in RL95-2 endometrial carcinoma cells. Food Chem. 2012, 133, 912-922. [CrossRef].
88. Lu, J.; Papp, L.V.; Fang, J.; Rodriguez-Nieto, S.; Zhivotovsky, B.; Holmgren, A. Inhibition of mammalian thioredoxin reductase by some flavonoids: Implications for myricetin and quercetin anticancer activity. Cancer Res. 2006, 66, 4410-4418. [CrossRef] [PubMed].
89. Agullo, G.; Gamet-Payrastre, L.; Manenti, S.; Viala, C.; Rémésy, C.; Chap, H.; Payrastre, B. Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: A comparison with tyrosine kinase and protein kinase C inhibition. Biochem. Pharmacol. 1997, 53, 1649-1657. [CrossRef].
90. Walker, E.H.; Pacold, M.E.; Perisic, O.; Stephens, L.; Hawkins, P.T.; Wymann, M.P.; Williams, R.L. Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine. Mol. Cell 2000, 6, 909-919. [CrossRef].
91. Yuan, C.H.; Filippova, M.; Tungteakkhun, S.S.; Duerksen-Hughes, P.J.; Krstenansky, J.L. Small molecule inhibitors of the HPV16-E6 interaction with caspase 8. Bioorg. Med. Chem. Lett. 2012, 22, 2125-2129. [CrossRef] [PubMed].
92. Bin, H.S.; Choi, U.K. Myricetin inhibits adipogenesis in human adipose tissue-derived mesenchymal stem cells. Food Sci. Biotechnol. 2012, 21, 1391-1396. [CrossRef].
93. Van Zanden, J.J.; de Mul, A.; Wortelboer, H.M.; Usta, M.; van Bladeren, P.J.; Rietjens, I.M.C.M.; Cnubben, N.H.P. Reversal of in vitro cellular MRP1 and MRP2 mediated vincristine resistance by the flavonoid myricetin. Biochem. Pharmacol. 2005, 69, 1657-1665. [CrossRef] [PubMed].
94. Durgo, K.; Vuković, L.; Rusak, G.; Osmak, M.; Čolić, J.F. Effect of flavonoids on glutathione level, lipid peroxidation and cytochrome P450 CYP1A1 expression in human laryngeal carcinoma cell lines. Food Technol. Biotechnol. 2007, 45, 69-79.
95. Xu, R.; Zhang, Y.; Ye, X.; Xue, S.; Shi, J.; Pan, J.; Chen, Q. Inhibition effects and induction of apoptosis of flavonoids on the prostate cancer cell line PC-3 in vitro. Food Chem. 2013, 138, 48-53. [CrossRef] [PubMed].
96. Sun, F.; Zheng, X.Y.; Ye, J.; Wu, T.T.; Wang, J.L.; Chen, W. Potential anticancer activity of myricetin in human T24 bladder cancer cells both in vitro and in vivo. Nutr. Cancer 2012, 64, 599-606. [CrossRef] [PubMed].
97. Zhang, X.; Ling, Y.; Yu, H.; Ji, Y. Studies on mechanism of myricetin-induced apoptosis in human hepatocellular carcinoma HepG-2 cells. Zhongguo Zhongyao Zazhi 2010, 35, 1046-1050. [PubMed].
98. Zhang, Q.; Zhao, X.H.;Wang, Z.J. Flavones and flavonols exert cytotoxic effects on a human oesophageal adenocarcinoma cell line (OE33) by causing G2/M arrest and inducing apoptosis. Food Chem. Toxicol. 2008, 46, 2042-2053. [CrossRef] [PubMed].
99. Zhang, Q.; Zhao, X.H.; Wang, Z.J. Cytotoxicity of flavones and flavonols to a human esophageal squamous cell carcinoma cell line (KYSE-510) by induction of G2/M arrest and apoptosis. Toxicol. Vitro 2009, 23, 797-807. [CrossRef] [PubMed].
100. Zhang, Q.; Zhao, X.H. Flavone-and flavonol-caused apoptosis in human esophageal cancer cells by inducing the expression of PIG3. Prog. Biochem. Biophys. 2009, 36, 213-219. [CrossRef].
101. Garcia, O.B.; Castillo, J.; Lorente, J.; Alcaraz, M.; Yanez, J.; Martinez, C.; Vicente, V.; Lozano, J.A. Antiproliferative activity of several phenolic compounds against melanoma cell lines: Relationship between structure and activity. Agro Food Ind. Hi-Tech 2005, 16, 30-34.
102. Labbe, D.; Provencal, M.; Lamy, S.; Boivin, D.; Gingras, D.; Béliveau, R. The flavonols quercetin, kaempferol, and myricetin inhibit hepatocyte growth factor-induced medulloblastoma cell migration. J. Nutr. 2009, 139, 646-652. [CrossRef] [PubMed].
103. Shih, Y.W.; Wu, P.F.; Lee, Y.C.; Shi, M.D.; Chiang, T.A. Myricetin suppresses invasion and migration of human lung adenocarcinoma a549 cells: Possible mediation by blocking the erk signaling pathway. J. Agric. Food Chem. 2009, 57, 3490-3499. [CrossRef] [PubMed].
104. Phillips, P.A.; Sangwan, V.; Borja-Cacho, D.; Dudeja, V.; Vickers, S.M.; Saluja, A.K. Myricetin induces pancreatic cancer cell death via the induction of apoptosis and inhibition of the phosphatidylinositol 3-kinase (PI3K) signaling pathway. Cancer Lett. 2011, 308, 181-188. [CrossRef] [PubMed].
105. Androutsopoulos, V.P.; Papakyriakou, A.; Vourloumis, D.; Spandidos, D.A. Comparative CYP1A1 and CYP1B1 substrate and inhibitor profile of dietary flavonoids. Bioorg. Med. Chem. 2011, 19, 2842-2849. [CrossRef] [PubMed].
106. Kim, M.E.; Ha, T.K.; Yoon, J.H.; Lee, J.S. Myricetin induces cell death of human colon cancer cells via BAX/BCL2-dependent pathway. Anticancer Res. 2014, 34, 701-706. [PubMed].
107. Schutte, M.E.; van de Sandt, J.J.M.; Alink, G.M.; Groten, J.P.; Rietjens, I.M.C.M. Myricetin stimulates the absorption of the pro-carcinogen PhIP. Cancer Lett. 2006, 231, 36-42. [CrossRef] [PubMed].
108. Anderson, D.; Dobrzynska, M.M.; Yu, T.W. Modulating effects of Silymarin and myricetin on food mutagens and doxorubicin in assays with different genetic endpoints. J. Environ. Pathol. Toxicol. Oncol. 1997, 16, 313-327.
109. Tzeng, S.H.; Ko,W.C.; Ko, F.N.; Teng, C.M. Inhibition of platelet aggregation by some flavonoids. Thromb. Res. 1991, 64, 91-100. [CrossRef].
110. Zang, B.X.; Jin, M.; Wu, W.; Chen, W.M.; Piao, Y.Z.; Li, J.R. Antagonistic effect of myricetin on platelet activing factor. Yaoxue Xuebao 2003, 38, 831-833.
111. Melzig, M.F.; Henke, K. Inhibition of thrombin activity by selected natural products in comparison to neutrophil elastase. Planta Med. 2005, 71, 787-789. [CrossRef] [PubMed].
112. Chen,W.M.; Jin, M.;Wu,W.; Li, J.R.; Zang, B.X.; Piao, Y.Z. Inhibitory effect of flavonols of Carthamus tinctorius L. against rabbit platelet activation induced by platelet activating factor. Yaoxue Xuebao 2001, 36, 884-885.
113. Liu, L.; Ma, H.; Yang, N.; Tang, Y.; Guo, J.; Tao, W.; Duan, J. A series of natural flavonoids as thrombin inhibitors: Structure-activity relationships. Thromb. Res. 2010, 126, e365-e378. [CrossRef] [PubMed].
114. Landolfi, R.; Mower, R.L.; Steiner, M. Modification of platelet function and arachidonic acid metabolism by bioflavonoids. Structure-activity relations. Biochem. Pharmacol. 1984, 33, 1525-1530. [CrossRef].
115. Robak, J.; Korbut, R.; Shridi, F.; Swies, J.; Rzadkowska-Bodalska, H. On the mechnaism of antiaggregatory effects of myricetin. Pol. J. Pharmacol. Pharm. 1988, 40, 337-340. [PubMed].
116. Tong, Y.; Zhou, X.M.;Wang, S.J.; Yang, Y.; Cao, Y.L. Analgesic activity of myricetin isolated from Myrica rubra Sieb. et Zucc. Leaves. Arch. Pharm. Res. 2009, 32, 527-533. [CrossRef] [PubMed].
117. Borde, P.; Mohan, M.; Kasture, S. Effect of myricetin on deoxycorticosterone acetate (DOCA)-salt-hypertensive rats. Nat. Prod. Res. 2011, 25, 1549-1559. [CrossRef] [PubMed].
118. Godse, S.; Mohan, M.; Kasture, V.; Kasture, S. Effect of myricetin on blood pressure and metabolic alterations in fructose hypertensive rats. Pharm. Biol. 2010, 48, 494-498. [CrossRef] [PubMed].
119. Kang, B.Y.; Kim, S.H.; Cho, D.; Kim, T.S. Inhibition of interleukin-12 production in mouse macrophages via decreased nuclear factor-kappaB DNA binding activity by myricetin, a naturally occurring flavonoid. Arch. Pharm. Res. 2005, 28, 274-279. [CrossRef] [PubMed].
120. Jimenez, R.; Andriambeloson, E.; Duarte, J.; Andriantsitohaina, R.; Jiménez, J.; Pérez-Vizcaino, F.; Zarzuelo, A.; Tamargo, J. Involvement of thromboxane A2 in the endothelium-dependent contractions induced by myricetin in rat isolated aorta. Br. J. Pharmacol. 1999, 127, 1539-1544. [CrossRef] [PubMed].
121. Cho, Y.C.; Yoon, G.; Kwang, Y.L.; Hyun, J.C.; Bok, Y.K. Inhibition of interleukin-2 production by myricetin in mouse EL-4 T cells. Arch. Pharm. Res. 2007, 30, 1075-1079. [CrossRef] [PubMed].
122. Yu, Y.; Zeng, Y.Y.; Liu, L.; Ji, Y.H.; Xing, F.Y.; Zhao, J.X. The effects of myrictin on inhibition of mouse lymphocytes activated in vitro. Chin. Pharmacol. Bull. 2006, 22, 63-66.
123. Grenier, D.; Chen, H.; Lagha, A.B.; Fournier-Larente, J.; Morin, M.P. Dual action of myricetin on Porphyromonas gingivalis and the inflammatory response of host cells: A promising therapeutic molecule for periodontal diseases. PLoS ONE 2015, 10, e0131758.
124. Ishikawa, Y.T.; Goto, M.; Yamaki, K. Structure-activity relations of inhibitory effects of various flavonoids on lipopolysaccharide-induced prostaglandin E2 production in rat peritoneal macrophages: Comparison between subclasses of flavonoids. Phytomedicine 2006, 13, 310-317. [CrossRef] [PubMed].
125. Kim, H.H.; Kim, D.H.; Kim, M.H.; Oh, M.H.; Kim, S.R.; Park, K.J.; Lee, M.W. Flavonoid constituents in the leaves of Myrica rubra sieb. et zucc. with anti-inflammatory activity. Arch. Pharm. Res. 2013, 36, 1533-1540. [CrossRef] [PubMed].
126. Lee, K.M.; Nam, J.K.; Jin, H.H.; Ki, W.L.; Hyong, J.L. Myricetin down-regulates phorbol ester-induced cyclooxygenase-2 expression in mouse epidermal cells by blocking activation of nuclear factor kappa B. J. Agric. Food Chem. 2007, 55, 9678-9684. [CrossRef] [PubMed].
127. Venegas, G.G.; Luna, O.A.; Arroyo, J.A.V.; Bermúdez, C.H. Myricetin suppresses lipoteichoic acid-induced interleukin-1β and cyclooxygenase-2 expression in human gingival fibroblasts. Microbiol. Immunol. 2013, 57, 849-856. [CrossRef] [PubMed].
128. Venegas, G.G.; Luna, O.A.; Cano, J.A.A.; Bermúdez, C.H. Myricetin blocks lipoteichoic acid-induced COX-2 expression in human gingival fibroblasts. Cell. Mol. Biol. Lett. 2014, 19, 126-139.
129. Ko, S.Y. Myricetin suppresses LPS-induced MMP expression in human gingival fibroblasts and inhibits osteoclastogenesis by downregulating NFATc1 in RANKL-induced RAW264.7 cells. Arch. Oral Biol. 2012, 57, 1623-1632. [CrossRef] [PubMed].
130. Kuo, P.L. Myricetin inhibits the induction of anti-Fas IgM-, tumor necrosis factor-β- and interleukin-1 β-mediated apoptosis by Fas pathway inhibition in human osteoblastic cell line MG-63. Life Sci. 2005, 77, 2964-2976. [CrossRef] [PubMed].
131. Lee, Y.S.; Choi, E.M. Myricetin inhibits IL-1β-induced inflammatory mediators in SW982 human synovial sarcoma cells. Int. Immunopharmacol. 2010, 10, 812-814. [CrossRef] [PubMed].
132. Zhao, J.; Hong, T.; Dong, M.; Meng, Y.; Mu, J. Protective effect of myricetin in dextran sulphate sodium-induced murine ulcerative colitis. Mol. Med. Rep. 2013, 7, 565-570. [PubMed].
133. Bai, H.W.; Zhu, B.T. Myricetin and quercetin are naturally occurring co-substrates of cyclooxygenases in vivo. Prostaglandins Leukot. Essent. Fatty Acids 2010, 82, 45-50. [CrossRef] [PubMed].
134. Medeiros, K.C.P.; Figueiredo, C.A.V.; Figueredo, T.B.; Freire, K.R.L.; Santos, F.A.R.; Neves, N.M.A.; Silva, T.M.S.; Piuvezam, M.R. Anti-allergic effect of bee pollen phenolic extract and myricetin in ovalbumin-sensitized mice. J. Ethnopharmacol. 2008, 119, 41-46. [CrossRef] [PubMed].
135. Park, H.H.; Lee, S.; Son, H.Y.; Park, S.B.; Kim, M.S.; Choi, E.J.; Singh, T.S.K.; Ha, J.H.; Lee, M.G.; Kim, J.E.; et al. Flavonoids inhibit histamine release and expression of proinflammatory cytokines in mast cells. Arch. Pharm. Res. 2008, 31, 1303-1311. [CrossRef] [PubMed].
136. 2+ channels. Eur. J. Pain 2010, 14, 992-998. [CrossRef] [PubMed].
137. Hagenacker, T.; Hillebrand, I.; Büsselberg, D.; Schäfers, M. Myricetin reduces voltage activated potassium channel currents in DRG neurons by a p38 dependent mechanism. Brain Res. Bull. 2010, 83, 292-296. [CrossRef] [PubMed].
138. Cordova, M.M.; Werner, M.F.D.P.; Silva, M.D.D.; Ruani, A.P.; Pizzolatti, M.G.; Santos, A.R.S. Further antinociceptive effects of myricitrin in chemical models of overt nociception in mice. Neurosci. Lett. 2011, 495, 173-177. [CrossRef] [PubMed].
139. Yamaguchi, M.; Hamamoto, R.; Uchiyama, S.; Ishiyama, K. Effects of flavonoid on calcium content in femoral tissue culture and parathyroid hormone-stimulated osteoclastogenesis in bone marrow culture in vitro. Mol. Cell. Biochem. 2007, 303, 83-88. [CrossRef] [PubMed].
140. Hsu, Y.L.; Chang, J.K.; Tsai, C.H.; Chien, T.T.C.; Kuo, P.L. Myricetin induces human osteoblast differentiation through bone morphogenetic protein-2/p38 mitogen-activated protein kinase pathway. Biochem. Pharmacol. 2007, 73, 504-514. [CrossRef] [PubMed].
141. Hyman, B.T.; van Hoesen, G.W.; Damasio, A.R.; Barnes, C.L. Alzheimer's disease: Cell-specific pathology isolates the hippocam-pal formation. Science 1984, 225, 1168-1170. [CrossRef] [PubMed].
142. Kanaan, N.M.; Himmelstein, D.S.; Ward, S.M.; Combs, B.; Binde, L.I. Tau Protein: Biology and Pathobiology. In Movement Disorders, 2nd ed.; Academic Press: New York, NY, USA, 2015; pp. 857-874.
143. Duyckaerts, C.; Delatour, B.; Potier, M.C. Classification and basic pathology of Alzheimer disease. Acta Neuropathol. 2009, 118, 5-36. [CrossRef] [PubMed].
144. Ono, K.; Yoshiike, Y.; Takashima, A.; Hasegawa, K.; Naiki, H.; Yamada, M. Potent anti-amyloidogenic and fibril-destabilizing effects of polyphenols in vitro: Implications for the prevention and therapeutics of Alzheimer's disease. J. Neurochem. 2003, 87, 172-181. [CrossRef] [PubMed].
145. Choi, Y.; Kim, T.D.; Paik, S.R.; Jeong, K.; Jung, S. Molecular simulations for anti-amyloidogenic effect of flavonoid myricetin exerted against Alzheimer's β-amyloid fibrils formation. Bull. Korean Chem. Soc. 2008, 29, 1505-1509.
146. Shimmyo, Y.; Kihara, T.; Akaike, A.; Niidome, T.; Sugimoto, H. Multifunction of myricetin on Aβ: Neuroprotection via a conformational change of Aβ and reduction of Aβ via the interference of secretases. J. Neurosci. Res. 2008, 86, 368-377. [CrossRef] [PubMed].
147. Chang, Y.; Chang, C.Y.; Wang, S.J.; Huang, S.K. Myricetin inhibits the release of glutamate in rat cerebrocortical nerve terminals. J. Med. Food 2015, 18, 516-523. [CrossRef] [PubMed].
148. Shimmyo, Y.; Kihara, T.; Akaike, A.; Niidome, T.; Sugimoto, H. Three distinct neuroprotective functions of myricetin against glutamate-induced neuronal cell death: Involvement of direct inhibition of caspase-3. J. Neurosci. Res. 2008, 86, 1836-1845. [CrossRef] [PubMed].
149. Tucci, P.; Mhillaj, E.; Morgese, M.G.; Colaianna, M.; Zotti, M.; Schiavone, S.; Cicerale, M.; Trezza, V.; Campolongo, P.; Cuomo, V.; et al. Memantine prevents memory consolidation failure induced by soluble beta amyloid in rats. Front. Behav. Neurosci. 2014, 8, 332. [CrossRef] [PubMed].
150. Ono, K.; Yamada, M. Antioxidant compounds have potent anti-fibrillogenic and fibril-destabilizing effects for α-synuclein fibrils in vitro. J. Neurochem. 2006, 97, 105-115. [CrossRef] [PubMed].
151. Caruana, M.; Högen, T.; Levin, J.; Hillmer, A.; Giese, A.; Vassallo, N. Inhibition and disaggregation of α-synuclein oligomers by natural polyphenolic compounds. FEBS Lett. 2011, 585, 1113-1120. [CrossRef] [PubMed].
152. Zhu, X.; Jia, Y.H. Inhibition of catechol-o-methyltransferase (COMT) by myricetin, dihydromyricetin and myricitrin. Pharmazie 2014, 69, 183-186. [PubMed].
153. Jimenez, M.F.M.; Reus, M.I.S.; Andres, D.; Cascales, M.; Benedi, J. Neuroprotective effect of fraxetin and myricetin against rotenone-induced apoptosis in neuroblastoma cells. Brain Res. 2004, 1009, 9-16. [CrossRef] [PubMed].
154. Laabich, A.; Manmoto, C.C.; Kuksa, V.; Leung, D.W.; Vissvesvaran, G.P.; Karliga, I.; Kamat, M.; Scott, I.L.; Fawzi, A.; Kubota, R. Protective effects of myricetin and related flavonols against A2E and light mediated-cell death in bovine retinal primary cell culture. Exp. Eye Res. 2007, 85, 154-165. [CrossRef] [PubMed].
155. Lei, Y.; Chen, J.; Zhang,W.; Fu,W.;Wu, G.;Wei, H.;Wang, Q.; Ruan, J. In vivo investigation on the potential of galangin, kaempferol and myricetin for protection of d-galactose-induced cognitive impairment. Food Chem. 2012, 135, 2702-2707. [CrossRef] [PubMed].
156. Liu, R.N.;Wang,W.; Ding, Y.; Xie,W.D.; Ma, C.; Du, L.J. A new flavonol glycoside and activity of compounds from the flower of Nymphaea candida. J. Asian Nat. Prod. Res. 2007, 9, 333-338. [CrossRef] [PubMed].
157. Mohan, M.; Jadhav, S.S.; Kasture, V.S.; Kasture, S.B. Effect of myricetin on behavioral paradigms of anxiety. Pharm. Biol. 2009, 47, 927-931. [CrossRef].
158. Moonrungsee, N.; Shimamura, T.; Kashiwagi, T.; Jakmunee, J.; Higuchi, K.; Ukeda, H. An automated sequential injection spectrophotometric method for evaluation of tyramine oxidase inhibitory activity of some flavonoids. Talanta 2014, 122, 257-263. [CrossRef] [PubMed].
159. Ma, Z.G.;Wang, J.; Jiang, H.; Liu, T.W.; Xie, J.X. Myricetin reduces 6-hydroxydopamine-induced dopamine neuron degeneration in rats. Neuroreport 2007, 18, 1181-1185. [CrossRef] [PubMed].
160. Franco, J.L.; Posser, T.; Missau, F.; Pizzolatti, M.G.; Santos, A.R.S.; Souza, D.O.; Aschner, M.; Rocha, J.B.T.; Dafre, A.L.; Farina, M. Structure-activity relationship of flavonoids derived from medicinal plants in preventing methylmercury-induced mitochondrial dysfunction. Environ. Toxicol. Pharmacol. 2010, 30, 272-278. [CrossRef] [PubMed].
161. Zhang, K.; Ma, Z.;Wang, J.; Xie, A.; Xie, J. Myricetin attenuated MPP+-induced cytotoxicity by anti-oxidation and inhibition of MKK4 and JNK activation in MES23.5 cells. Neuropharmacology 2011, 61, 329-335. [CrossRef] [PubMed].
162. 2+ channels and CaMK-II pathway. Evid. Based Complement. Altern. Med. 2012, 2012, 758097. [CrossRef] [PubMed].
163. Yang, Y.; Choi, J.K.; Jung, C.H.; Koh, H.J.; Heo, P.; Shin, J.Y.; Kim, S.; Park, W.S.; Shin, H.J.; Kweon, D.H. SNARE-wedging polyphenols as small molecular botox. Planta Med. 2012, 78, 233-236. [CrossRef] [PubMed].
164. Ma, Z.G.; Liu, T.W. Myricetin facilitates potassium currents and inhibits neuronal activity of PVN neurons. Neurochem. Res. 2012, 37, 1450-1456. [CrossRef] [PubMed].
165. Matic, S.; Stanic, S.; Bogojevic, D.; Vidakovic, M.; Grdovic, N.; Dinic, S.; Solujic, S.; Mladenovic, M.; Stankovic, N.; Mihailovic, M. Methanol extract from the stem of Cotinus coggygria Scop., and its major bioactive phytochemical constituent myricetin modulate pyrogallol-induced DNA damage and liver injury. Mutat. Res. 2013, 755, 81-89. [CrossRef] [PubMed].
166. Mo, S.F.; Zhou, F.; Lv, Y.Z.; Hu, Q.H.; Zhang, D.M.; Kong, L.D. Hypouricemic action of selected flavonoids in mice: Structure-activity relationships. Biol. Pharm. Bull. 2007, 30, 1551-1556. [CrossRef] [PubMed].
167. Lee, S.E.; Park, Y.S. Gene expression profiling of human umbilical vein endothelial cells exposed to myricetin. Biochip J. 2013, 7, 335-343. [CrossRef].
168. 2+]i in cardiomyocytes of rats. Chin. J. Epidemiol. 2007, 26, 624-626.
169. Scarabelli, T.M.; Mariotto, S.; Azeim, S.A.; Shoji, K.; Darra, E.; Stephanou, A.; Scarabelli, C.C.; Marechal, J.D.; Knight, R.; Ciampa, A.; et al. Targeting STAT1 by myricetin and delphinidin provides efficient protection of the heart from ischemia/reperfusion-induced injury. FEBS Lett. 2009, 583, 531-541. [CrossRef] [PubMed].
170. Wang, L.W.; Liu, F.Z.; Lu, J.K.; Liu, Y.C.; Yang, B.F. Effect of flavonols on caspase-3, Bcl-2 and bax expression in cardiomyocytes apoptosis. Chin. Pharm. J. 2007, 42, 749-753.
171. +-ATPase in the contractile response induced by myricetin in rat isolated aorta. Planta Med. 2002, 68, 133-137. [CrossRef] [PubMed].
172. Tiwari, R.; Mohan, M.; Kasture, S.; Maxia, A.; Ballero, M. Cardioprotective potential of myricetin in isoproterenol-induced myocardial infarction inWistar rats. Phytother. Res. 2009, 23, 1361-1366. [CrossRef] [PubMed].
173. Lian, T.W.; Wang, L.; Lo, Y.H.; Huang, I.J.; Wu, M.J. Fisetin, morin and myricetin attenuate CD36 expression and oxLDL uptake in U937-derived macrophages. Biochim. Biophys. Acta 2008, 1781, 601-609. [CrossRef] [PubMed].
174. Angelone, T.; Pasqua, T.; di Majo, D.; Quintieri, A.M.; Filice, E.; Amodio, N.; Tota, B.; Giammanco, M.; Cerra, M.C. Distinct signalling mechanisms are involved in the dissimilar myocardial and coronary effects elicited by quercetin and myricetin, two red wine flavonols. Nutr. Metab. Cardiovasc. Dis. 2011, 21, 362-371. [CrossRef] [PubMed].
175. Bhatia, G.; Khanna, A.K.; Sonkar, R.; Mishra, S.K.; Srivastava, S.; Lakshmi, V. Lipid lowering and antioxidant activity of flavones in triton treated hyperlipidemic rats. Med. Chem. Res. 2011, 20, 1622-1626. [CrossRef].
176. Mohan, M.; Gupta, S.K.; Agnihotri, S.; Joshi, S.; Uppal, A.K. Anti-cataract effect of topical quercetin and myricetin in galactosemic rats. Med. Sci. Res. 1988, 16, 685-686.
177. Hodges, L.C.; Kearse, E.C.; Green, K. Intraocular pressure-lowering activity of phenolic antioxidants in normotensive rabbits. Curr. Eye Res. 1999, 19, 234-240. [CrossRef] [PubMed].
178. Chen, R.; Hollborn, M.; Grosche, A.; Reichenbach, A.;Wiedemann, P.; Bringmann, A.; Kohen, L. Effects of the vegetable polyphenols epigallocatechin-3-gallate, luteolin, apigenin, myricetin, quercetin, and cyanidin in primary cultures of human retinal pigment epithelial cells. Mol. Vis. 2014, 20, 242-258. [PubMed].
179. Ong, K.C.; Khoo, H.E. Insulinomimetic effects of myricetin on lipogenesis and glucose transport in rat adipocytes but not glucose transporter translocation. Biochem. Pharmacol. 1996, 51, 423-429. [CrossRef].
180. Ong, K.C.; Khoo, H.E. Effects of myricetin on glycemia and glycogen metabolism in diabetic rats. Life Sci. 2000, 67, 1695-1705. [CrossRef].
181. Zelus, C.; Fox, A.; Calciano, A.; Faridian, B.S.; Nogaj, L.A.; Moffet, D.A. Myricetin inhibits islet amyloid polypeptide (IAPP) aggregation and rescues living mammalian cells from IAPP toxicity. Open Biochem. J. 2012, 6, 66-70. [CrossRef] [PubMed].
182. Liu, I.M.; Tzeng, T.F.; Liou, S.S. Myricetin ameliorates defective post-receptor insulin signaling via β-endorphin signaling in the skeletal muscles of fructose-fed rats. Evid. Based Complement. Altern. Med. 2011, 2011, 150752.
183. Kang, S.J.; Park, J.H.Y.; Choi, H.N.; Kim, J.I. α-glucosidase inhibitory activities of myricetin in animal models of diabetes mellitus. Food Sci. Biotechnol. 2015, 24, 1897-1900. [CrossRef].
184. Liu, I.M.; Tzeng, T.F.; Liou, S.S.; Lan, T.W. Improvement of insulin sensitivity in obese Zucker rats by myricetin extracted from Abelmoschus moschatus. Planta Med. 2007, 73, 1054-1060. [CrossRef] [PubMed].
185. Ding, Y.; Dai, X.; Zhang, Z.; Li, Y. Myricetin attenuates hyperinsulinemia-induced insulin resistance in skeletal muscle cells. Eur. Food Res. Technol. 2012, 234, 873-881. [CrossRef].
186. Lee, K.H.; Choi, E.M. Myricetin, a naturally occurring flavonoid, prevents 2-deoxy-d-ribose induced dysfunction and oxidative damage in osteoblastic MC3T3-E1 cells. Eur. J. Pharmacol. 2008, 591, 1-6. [CrossRef] [PubMed].
187. Ozcan, F.; Ozmen, A.; Akkaya, B.; Aliciguzel, Y.; Aslan, M. Beneficial effect of myricetin on renal functions in streptozotocin-induced diabetes. Clin. Exp. Med. 2012, 12, 265-272. [CrossRef] [PubMed].
188. Liu, I.M.; Liou, S.S.; Cheng, J.T. Mediation of β-endorphin by myricetin to lower plasma glucose in streptozotocin-induced diabetic rats. J. Ethnopharmacol. 2006, 104, 199-206. [CrossRef] [PubMed].
189. Kandasamy, N.; Ashokkumar, N. Myricetin modulates streptozotocin-cadmium induced oxidative stress in long term experimental diabetic nephrotoxic rats. J. Funct. Foods 2013, 5, 1466-1477. [CrossRef].
190. Ding, Y.; Dai, X.Q.; Zhang, Z.F.; Li, Y. Upregulation ofWnt signal pathway by myricetin attenuates β-cell dysfunction induced by cytokines. Prog. Biochem. Biophys. 2013, 40, 50-56. [CrossRef].
191. Williams, L.K.; Li, C.; Withers, S.G.; Brayer, G.D. Order and disorder: Differential structural impacts of myricetin and ethyl caffeate on human amylase, an antidiabetic target. J. Med. Chem. 2012, 55, 10177-10186. [CrossRef] [PubMed].
192. Gebhardt, R. Variable Influence of Kaempferol and Myricetin on in vitro Hepatocellular Cholesterol Biosynthesis. Planta Med. 2003, 69, 1071-1074. [PubMed].
193. Chang, C.J.; Tzeng, T.F.; Liou, S.S.; Chang, Y.S.; Liu, I.M. Myricetin increases hepatic peroxisome proliferator-activated receptor protein expression and decreases plasma lipids and adiposity in rats. Evid. Based Complement. Altern. Med. 2012, 2012, 787152. [CrossRef] [PubMed].
194. Cai, L.; Wu, C.D. Compounds from Syzygium aromaticum possessing growth inhibitory activity against oral pathogens. J. Nat. Prod. 1996, 59, 987-990. [CrossRef] [PubMed].
195. Jayaraman, P.; Sakharkar, M.K.; Lim, C.S.; Tang, T.H.; Sakharkar, K.R. Activity and interactions of antibiotic and phytochemical combinations against Pseudomonas aeruginosa in vitro. Int. J. Biol. Sci. 2010, 6, 556-568. [CrossRef] [PubMed].
196. Lin, R.D.; Chin, Y.P.; Lee, M.H. Antimicrobial activity of antibiotics in combination with natural flavonoids against clinical extended-spectrum β-lactamase (ESBL)-producing Klebsiella pneumonia. Phytother. Res. 2005, 19, 612-617. [CrossRef] [PubMed].
197. D'Souza, L.; Wahidulla, S.; Devi, P. Antibacterial phenolics from the mangrove Lumnitzera racemosa. Indian J. Mar. Sci. 2010, 39, 294-298.
198. Griep, M.A.; Blood, S.; Larson, M.A.; Koepsell, S.A.; Hinrichs, S.H. Myricetin inhibits Escherichia coli DnaB helicase but not primase. Bioorg. Med. Chem. 2007, 15, 7203-7208. [CrossRef] [PubMed].
199. Xu, H.X.; Lee, S.F. Activity of plant flavonoids against antibiotic-resistant bacteria. Phytother. Res. 2001, 15, 39-43. [CrossRef].
200. Kang, S.S.; Kim, J.G.; Lee, T.H.; Oh, K.B. Flavonols inhibit sortases and sortase-mediated Staphylococcus aureus clumping to fibrinogen. Biol. Pharm. Bull. 2006, 29, 1751-1755. [CrossRef] [PubMed].
201. Naz, S.; Siddiqi, R.; Ahmad, S.; Rasool, S.A.; Sayeed, S.A. Antibacterial activity directed isolation of compounds from Punica granatum. J. Food Sci. 2007, 72, M341-M345. [CrossRef] [PubMed].
202. Yadav, A.K.; Thakur, J.; Prakash, O.; Khan, F.; Saikia, D.; Gupta, M.M. Screening of flavonoids for antitubercular activity and their structure-activity relationships. Med. Chem. Res. 2013, 22, 2706-2716. [CrossRef].
203. Ono, K.; Nakane, H.; Fukushima, M.; Chermann, J.C.; Barré-Sinoussi, F. Differential inhibitory effects of various flavonoids on the activities of reverse transcriptase and cellular DNA and RNA polymerases. Eur. J. Biochem. 1990, 190, 469-476. [CrossRef] [PubMed].
204. Veljkovic, V.; Mouscadet, J.F.; Veljkovic, N.; Glisic, S.; Debyser, Z. Simple criterion for selection of flavonoid compounds with anti-HIV activity. Bioorg. Med. Chem. Lett. 2007, 17, 1226-1232. [CrossRef] [PubMed].
205. Yang, G.X.; Qi, J.-B.; Cheng, K.J.; Hu, C.Q. Anti-HIV chemical constituents of aerial parts of Caragana rosea. Yaoxue Xuebao 2007, 42, 179-182.
206. Chu, S.C.; Hsieh, Y.S.; Lin, J.Y. Inhibitory effects of flavonoids on moloney murine leukemia virus reverse transcriptase activity. J. Nat. Prod. 1992, 55, 179-183. [CrossRef] [PubMed].
207. Yu, M.S.; Lee, J.; Lee, J.M.; Kim, Y.; Chin, Y.W.; Jee, J.G.; Keum, Y.S.; Jeong, Y.J. Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13. Bioorg. Med. Chem. Lett. 2012, 22, 4049-4054. [CrossRef] [PubMed].
208. Keum, Y.S.; Jeong, Y.J. Development of chemical inhibitors of the SARS coronavirus: Viral helicase as a potential target. Biochem. Pharmacol. 2012, 84, 1351-1358. [CrossRef] [PubMed].
209. Shin, J.C.; Jung, H.Y.; Harikishore, A.; Kwon, O.D.; Yoon, H.S.; Kim, K.T.; Choi, B.H. The flavonoid myricetin reduces nocturnal melatonin levels in the blood through the inhibition of serotonin N-acetyltransferase. Biochem. Biophys. Res. Commun. 2013, 440, 312-316. [CrossRef] [PubMed].
210. 2+ pump kinetics and structure-function relationships. Biochem. Pharmacol. 1991, 41, 669-675. [CrossRef].
211. Pereira, T.A.; Das, N.P. Assay of liver cytosol lipoxygenase by differential pulse polarography. Anal. Biochem. 1991, 197, 96-100. [CrossRef].
212. Yuksel, S.; Yesilada, E.; Gulbay, G.; Kurtoglu, E.; Serap Savaci, S. Protective effect of myricetin against e2-induced genotoxic damage in human lymphocytes. Fresen. Environ. Bull. 2012, 21, 1022-1026.
213. Panickar, K.S.; Anderson, R.A. Mechanisms underlying the protective effects of myricetin and quercetin following oxygen-glucose deprivation-induced cell swelling and the reduction in glutamate uptake in glial cells. Neuroscience 2011, 183, 1-14. [CrossRef] [PubMed].
214. Barlas, N.; Ozer, S.; Karabulut, G. The estrogenic effects of apigenin, phloretin and myricetin based on uterotrophic assay in immatureWistar albino rats. Toxicol. Lett. 2014, 226, 35-42. [CrossRef] [PubMed].
215. Chen, Y.H.; Yang, Z.S.; Wen, C.C.; Chang, Y.S.; Wang, B.C.; Hsiao, C.A.; Shih, T.L. Evaluation of the structure-activity relationship of flavonoids as antioxidants and toxicants of zebrafish larvae. Food Chem. 2012, 134, 717-724. [CrossRef] [PubMed].
216. Kim, J.D.; Liu, L.; Guo, W.; Meydani, M. Chemical structure of flavonols in relation to modulation of angiogenesis and immune-endothelial cell adhesion. J. Nutr. Biochem. 2006, 17, 165-176. [CrossRef] [PubMed].
217. Canada, A.T.; Watkins, W.D.; Nguyen, T.D. The toxicity of flavonoids to guinea pig enterocytes. Toxicol. Appl. Pharmacol. 1989, 99, 357-361. [CrossRef].
218. Song, Y.; Zhang, Y.M.; Xu, J.; Hua, R. Periphery analgesic effect of myricetin on a rat model of inflammatory pain. Chin. Pharmacol. Bull. 2015, 31, 1108-1111.
219. Smith, C.; Halliwell, B.; Aruoma, O.I. Protection by albumin against the pro-oxidant actions of phenolic dietary components. Food Chem. Toxicol. 1992, 30, 483-489. [CrossRef].
220. Hakkinen, S.H.; Karenlampi, S.O.; Mykkanen, H.M.; Torronen, A.R. Influence of domestic processing and storage on flavonol contents in berries. J. Agric. Food Chem. 2000, 48, 2960-2965. [CrossRef] [PubMed].